Definitive Healthcare Corp
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
DH$1.19+6.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share amounts and per share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $59,191 | $63,480 |
| Cost of revenue: | ||
| Cost of revenue exclusive of amortization | 10,141 | 9,736 |
| Amortization | 5,290 | 3,362 |
| Gross profit | 43,760 | 50,382 |
| Operating expenses: | ||
| Sales and marketing | 20,653 | 21,760 |
| Product development | 9,301 | 10,132 |
| General and administrative | 12,269 | 16,883 |
| Depreciation and amortization | 8,527 | 9,322 |
| Transaction, integration, and restructuring expenses | 1,265 | 8,534 |
| Goodwill impairment | 176,531 | — |
| Total operating expenses | 228,546 | 66,631 |
| Loss from operations | (184,786) | (16,249) |
| Other income (expense), net: | ||
| Interest income | 2,052 | 3,927 |
| Interest expense | (2,433) | (3,816) |
| Gain on remeasurement of tax receivable agreement liability | 20,664 | 2,267 |
| Loss on partial extinguishment of debt | (507) | — |
| Other (expense) income, net | (969) | 373 |
| Total other income, net | 18,807 | 2,751 |
| Net loss before income taxes | (165,979) | (13,498) |
| Benefit from income taxes | 10,886 | 780 |
| Net loss | (155,093) | (12,718) |
| Less: Net loss attributable to noncontrolling interests | (47,865) | (3,200) |
| Net loss attributable to Definitive Healthcare Corp. | $(107,228) | $(9,518) |
| Net loss per share of Class A Common Stock: | ||
| Basic and diluted | $(0.95) | $(0.08) |
| Weighted average Class A Common Stock outstanding: | ||
| Basic and diluted | 112,782,505 | 117,433,520 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.